Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability (Q48121689)

8 February 2018

title

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability (English)

1 reference

8 February 2018

0 references

1 reference

Easter A

1 reference

8 February 2018

Sharp TH

series ordinal

1 reference

8 February 2018

Valentin JP

series ordinal

1 reference

8 February 2018

Pollard CE

series ordinal

1 reference

8 February 2018

publication date

24 May 2007

1 reference

8 February 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

8 February 2018

volume

1 reference

8 February 2018

issue

1 reference

8 February 2018

page(s)

223-233

1 reference

8 February 2018

Aconitine inhibits epileptiform activity in rat hippocampal slices

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Penicillin induced hyperexcitability in the in vitro hippocampal slice can be unrelated to impairment of somatic inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Populations at risk for penicillin-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Enhancement of synaptic transmission by 4-aminopyridine in hippocampal slices of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

A specific effect of morphine on evoked activity in the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

The in vitro brain slice as a useful neurophysiological preparation for intracellular recording

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Proposal for Classification of Epilepsies and Epileptic Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Effects of sequential exposure to multiple concentrations of methylmercury in the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Triethyltin exposure suppresses synaptic transmission in area CA1 of the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

The in vitro hippocampal slice preparation as a screen for neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Effect of iomeprol on rat hippocampal slice synaptic transmission: comparison with other X-ray contrast agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Picrotoxin-induced epileptiform activity in hippocampus: role of endogenous versus synaptic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

A guinea pig hippocampal slice model of organophosphate-induced seizure activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Nonconvulsive status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Quantitative evaluation of the potencies of GABA-receptor agonists and antagonists using the rat hippocampal slice preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Effects of pentetrazol on neuronal activity and on extracellular calcium concentration in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Seizures with antidepressants: an in vitro technique to assess relative risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Neurotoxicity of penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Theophylline-induced seizures in a 6-month-old girl. Serum and cerebrospinal fluid levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Neuroleptic-induced seizures. An in vitro technique for assessing relative risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Seizures associated with poisoning and drug overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Primed-burst potentiation occludes the potentiation phenomenon and enhances the epileptiform activity induced by transient pentylenetetrazol in the CA1 region of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Interictal EEG and the diagnosis of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Microdialysis--theoretical background and recent implementation in applied life-sciences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

New perspectives in CNS safety pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Modification of seizure activity by electrical stimulation. I. After-discharge threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Safety pharmacology--a progressive approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Cysteamine pre-treatment reduces pentylenetetrazol-induced plasticity and epileptiform discharge in the CA1 region of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Role of the hippocampus in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Critical volume of rat cortex and extracellular threshold concentration for a pentylenetetrazol-induced epileptic focus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Adverse events in phase-I studies: a report in 1015 healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

The contrasting effects of dendrotoxins and other potassium channel blockers in the CA1 and dentate gyrus regions of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Poisoning with 4-Aminopyridine: Report of Three Cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Design and application of a novel brain slice system that permits independent electrophysiological recordings from multiple slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

The application of in vitro methods to safety pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Antibiotic-induced convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

NMDA receptor antagonists attenuate a portion of the penicillin-induced epileptiform burst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Analeptic use in clinical toxicology: a historical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Clinical features, pathogenesis and management of drug-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2007.04.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2007.04.008

1 reference

8 February 2018

1 reference

8 February 2018